title: Pandemic (H1N1) 2009 influenza with neurological complications diagnosed using specific serology with the haemagglutinin inhibition assay.
authors.forename: Brendan
authors.initials: B
authors.lastname: McMullan
authors.forename: Gabriel
authors.initials: G
authors.lastname: Dabscheck
authors.forename: Peter
authors.initials: P
authors.lastname: Robertson
authors.forename: Heather
authors.initials: H
authors.lastname: Johnston
authors.forename: William
authors.initials: W
authors.lastname: Rawlinson
authors.forename: Tony
authors.initials: T
authors.lastname: Walls
mesh_terms: D000293:Adolescent; D000914:Antibodies, Viral / Q000276:immunology*; D000927:Anticonvulsants / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000276:immunology*; D006801:Humans; D007124:Immunoenzyme Techniques; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology / Q000302:isolation & purification*; D007251:Influenza, Human / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D053139:Oseltamivir / Q000627:therapeutic use; D012698:Serologic Tests; D013226:Status Epilepticus / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000914:Antibodies, Viral; D000927:Anticonvulsants; D000998:Antiviral Agents; C543345:H1N1 virus hemagglutinin; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D053139:Oseltamivir; D008775:Methylprednisolone